Fastly (NASDAQ:FSLY) shares are pulling back in pre-market trading, giving back part of a sharp two-day rally that followed the company's new AI security platform launch and its Investor Day presentation.
Intel (NASDAQ:INTC) shares are pulling back sharply in pre-market trading, tracking a broader semiconductor and technology sector selloff as surging Treasury yields and renewedInflationfears prompt investors to take profits after a strong recent rally.
Meta Platforms (NASDAQ:META) shares are pulling back in pre-market trading following Wednesday's Connect 2026 keynote, as investors weigh a lack of concrete adoption metrics for the company's Muse AI assistant against an otherwise constructive wave of analyst reactions.
Marvell Technology (NASDAQ:MRVL) shares are set to open lower in pre-market trade, tracking a broader semiconductor and technology pullback as surging Treasury yields reignite inflation concerns and reassess AI-related valuations after last week's rally.
NVIDIA (NASDAQ:NVDA) shares are trading lower in pre-market action, falling roughly 1.2% as a broad risk-off move grips markets after the 10-year Treasury yield spiked to 5.11% following weak demand at a five-year note auction that reignitedInflationand further Fed rate-hike concerns.
Everpure (NYSE:P) shares are surging in pre-market trading after the company used its 2026 Financial Analyst Meeting to lay out aLong-term Growthoutlook built around expansion well beyond its original storage business.
Slide Insurance Holdings (NASDAQ:SLDE) shares are rebounding in pre-market trading, up roughly 5% after closing down 3.8% in the prior session, as investors weigh the company's newly expanded product suite launched in South Carolina.
Dropbox (NASDAQ:DBX) shares are sliding in pre-market trading after a rating firm downgraded the stock to Sell from Neutral and cut its price target, citing skepticism about the company's ability to pivot its core storage business toward AI-enhanced offerings.
Arm Holdings (NASDAQ:ARM) shares are pulling back in pre-market trading, falling roughly 3.8% after a blistering run that saw the stock spike more than 17% earlier this week alongside a broader AI and semiconductor rally, its strongest weekly performance since 2007.
Viking Therapeutics (NASDAQ:VKTX) shares are pulling back sharply pre-market after the company priced an upsized offering of common stock and convertible senior notes, raising dilution concerns among investors. The company priced 7,857,143 shares of common stock at $35.00 per share and $225 million in …